Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-27 · accession 0000950170-23-050807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-29 | 2023-09-27 | INKT | Buell Jennifer | CEO | M - OptEx | — | +695.8K | 1.08M | +183% | — |
| D | 2023-09-29 | 2023-09-27 | INKT | Buell Jennifer | CEO | M - OptEx | $0.00 | -695.8K | 695.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-27 | M | A | 695,750 | — | 1,076,465 | D | — | — | (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. |
| 2 | Derivative | Restricted Stock Unit | 2023-09-27 | M | D | 695,750 | $0.00 | 695,750 | D | — · — to — | 0 Common Stock | (F1) Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. (F2) Represents restricted stock unit convertible into an equivalent number of shares of our common stock, which vested as to 100% of the underlying shares on September 27, 2023. |